Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2001;15(6):319-23.
doi: 10.1002/jcla.1044.

Homogenous enzyme immunoassay for cyclosporine in whole blood using the EMIT 2000 cyclosporine specific assay with the COBAS MIRA-plus analyzer

Affiliations
Comparative Study

Homogenous enzyme immunoassay for cyclosporine in whole blood using the EMIT 2000 cyclosporine specific assay with the COBAS MIRA-plus analyzer

S Kimura et al. J Clin Lab Anal. 2001.

Abstract

We describe the evaluation of the EMIT 2000 cyclosporine specific assay kit, an enzyme-multiplied immunoassay for cyclosporine in whole blood, with a COBAS MIRA-plus analyzer. The enzyme used for the assay was glucose-6-phosphate dehydrogenase (EC 1.1.1.49 G6PDH) from Leuconostoc mesenteroides; the monoclonal antibody is fairly specific for cyclosporine, and is not reactive with most metabolites. The assay principle is based on competitive immunoassay with G6PDH-labeled cyclosporine and cyclosporine in sample to the anticyclosporine mouse monoclonal antibody binding site. The within-assay coefficient of variation (CV) of this method was 2.7-4.2% (n = 10) at the levels of 56.2-339.7 microg/L. Day-to-day CVs ranged from 4.2-8.1% at the levels of 47.2-350.2 microg/L. The within-day CVs ranged from 2.0-6.4% at the levels of 43.3-330.5 microg/L. The functional detection limit was 24.9 microg/L. Samples treated with pretreatment reagent were stable at least 5 hr. Calibration was stable at least 10 days. The analytical recovery was 81-109%. The correlation between values obtained with the EMIT 2000 cyclosporine specific assay kit (y) and fluorescence polarization immunoassay (FPIA) (TDxFLx) (x) was: y = 0.880x - 13.053 microg/L (r = 0.984, Sy/x = 15.968, n = 71) with a mean difference of 31.42 +/- 19.89 microg/L ((TDxFLx - EMIT 2000) +/- SD); for the FPIA (AxSYM) (x): y = 0.989 - 4.144 microg/L (r = 0.981, Sy/x = 17.478, n = 71) with a mean difference of 5.56 +/- 17.38 microg/L ((AxSYM - EMIT 2000) +/- SD); and for the radioimmunoassay (RIA, CYCLO-Trac SP) (x): y = 0.893 - 6.764 microg/L (r = 0.993, Sy/x = 10.582, n = 71) with a mean difference of 22.18 +/- 14.98 microg/L ((RIA - EMIT 2000) +/- SD) using the Bland-Altman technique.

PubMed Disclaimer

Similar articles

Cited by

References

    1. White DJG. 1982. Cyclosporin A: Clinical pharmacology and therapeutic potential. Drugs 24:322–334. - PubMed
    1. Stein CM, Murray JJ, Wood AJJ. 1999. Inhibition of stimulated interleukin‐2 production in whole blood: a practical measure of cyclosporine effect. Clin Chem 45:1477–1484. - PubMed
    1. Kalman VK, Klimpel GR. 1983. Cyclosporine A inhibits the production of gamma interferon (IFNγ) but does not inhibit production of virus‐induced IFNα/β . Cell Immunol 78:122–129. - PubMed
    1. Shaw LM, Kaplan B, Kaufman D. 1996. Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them. Clin Chem 42:1316–1321. - PubMed
    1. Gupta SK, Benet LZ. 1989. HPLC measurement of cyclosporine in blood, plasma and urine and simultaneous measurement of its four metabolites in blood. J Liq Chromatogr 12:1451–1462.

Publication types

MeSH terms

LinkOut - more resources